These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 15782728

  • 1. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
    O'Doherty M, Lanigan B, Breathnach F, O'Meara A, Gallie B, Chan H, O'Keefe M.
    Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
    [Abstract] [Full Text] [Related]

  • 2. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]

  • 3. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 4. Retinoblastoma in Turkey--treatment and prognosis.
    Günalp I, Gündüz K, Arslan Y.
    Jpn J Ophthalmol; 1996 Jan; 40(1):95-102. PubMed ID: 8739506
    [Abstract] [Full Text] [Related]

  • 5. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
    Chan MP, Hungerford JL, Kingston JE, Plowman PN.
    Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
    [Abstract] [Full Text] [Related]

  • 6. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 7. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 8. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.
    Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
    [Abstract] [Full Text] [Related]

  • 9. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
    Sovinz P, Urban C, Lackner H, Benesch M, Langmann G.
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
    [Abstract] [Full Text] [Related]

  • 10. [Radiotherapy in the treatment of retinoblastoma: about 40 cases].
    Frikha H, Chaari N, Nasr C, Bouguila H, Chebbi A, Bhouri L, Hentati D, Kochbati L, Besbes M, Rifi H, Oubiche F, Ayed S, Maalej M.
    Cancer Radiother; 2009 Jan; 13(1):30-6. PubMed ID: 18790660
    [Abstract] [Full Text] [Related]

  • 11. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
    Lumbroso L, Doz F, Levy C, Dendale R, Vedrenne J, Bours D, Zucker JM, Asselain B, Desjardins L.
    J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
    [Abstract] [Full Text] [Related]

  • 12. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
    Abramson DH, Schefler AC.
    Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
    [Abstract] [Full Text] [Related]

  • 13. [Intraocular retinoblastoma: new therapeutic options].
    Imhof SM, Moll AC, Schouten-van Meeteren AY.
    Ned Tijdschr Geneeskd; 2001 Nov 10; 145(45):2165-70. PubMed ID: 11727614
    [Abstract] [Full Text] [Related]

  • 14. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L, Aerts I, Lévy-Gabriel C, Dendale R, Sastre X, Esteve M, Asselain B, Bours D, Doz F, Desjardins L.
    Ophthalmology; 2008 Aug 10; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [Abstract] [Full Text] [Related]

  • 15. [Current treatment of retinoblastoma. 153 children treated between 1995 and 1998].
    Desjardins L, Levy C, Lumbroso L, Doz F, Schlienger P, Validire P, Asselain B, Bours D, Zucker JM.
    J Fr Ophtalmol; 2000 May 10; 23(5):475-81. PubMed ID: 10844307
    [Abstract] [Full Text] [Related]

  • 16. [Retinoblatoma: a review].
    Doz F.
    Arch Pediatr; 2006 Oct 10; 13(10):1329-37. PubMed ID: 16930963
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
    Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL.
    Pediatr Blood Cancer; 2013 Apr 10; 60(4):688-93. PubMed ID: 22997170
    [Abstract] [Full Text] [Related]

  • 18. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul 10; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

  • 19. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug 10; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 20. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J, Xue K, Gao YJ, Yuan YF, Shan HD, Bi YW.
    Zhonghua Yan Ke Za Zhi; 2010 Apr 10; 46(4):312-6. PubMed ID: 20654057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.